John Patience - 02 Jan 2026 Form 4 Insider Report for BIODESIX INC (BDSX)

Reporting relationship: Director, Chairman
Issuer ticker: BDSX
Reported as of: 02 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Jan 2026, 16:26:46 UTC
Prior SEC filing: 02 Oct 2025
Next SEC filing: 02 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Robin H. Cowie as Attorney-in-Fact for John Patience

Key filing fact

John Patience filed Form 4 for BIODESIX INC (BDSX) on 06 Jan 2026.

Key facts

This page summarizes John Patience's Form 4 filing for BIODESIX INC (BDSX).
4 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 06 Jan 2026, 16:26.

Change

Previous filing in this sequence was filed on 02 Oct 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001021413 Primary reporting owner

PATIENCE JOHN

Relationship: Director, Chairman
Address: 919 WEST DILLON RD, LOUISVILLE
Signature: /s/ Robin H. Cowie as Attorney-in-Fact for John Patience
Signature date: 06 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BDSX transaction

Common Stock

Options Exercise

Transaction value
Shares: +1,143
Change %: +5.3%
Price
Shares after: 22,661
Date: 05 Jan 2026
Ownership: Direct
Footnotes: F1

BDSX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 107,664
Date: 02 Jan 2026
Ownership: By Patience Enterprises LP
Footnotes: F2

BDSX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 241,480
Date: 02 Jan 2026
Ownership: By John Patience Living Trust dated 7/23/1993
Footnotes: F3

BDSX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,649
Date: 02 Jan 2026
Ownership: By Spouse

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BDSX transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +5,443
Change %
Price: $0.000000
Shares after: 5,443
Date: 02 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,443
Exercise price
Footnotes: F1, F4

BDSX transaction Derivative

Stock Options (Right to Buy)

Award

Transaction value: $0
Shares: +6,354
Change %
Price: $0.000000
Shares after: 6,354
Date: 02 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,354
Exercise price: $6.46
Footnotes: F5

BDSX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -1,143
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 05 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,143
Exercise price
Footnotes: F1, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock ("Common Stock").

Footnote F2

The Reporting Person is the sole general partner of Patience Enterprises LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Footnote F3

The Reporting Person is the sole trustee of John Patience Living Trust (July 23, 1993).

Footnote F4

These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.

Footnote F5

This option vests in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer.

Footnote F6

These RSUs vested in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and had no expiration date.